On October 31, 2019 Grey Wolf reported that it will be attending the SITC (Free SITC Whitepaper) 2019 conference from 6th-10th November in Maryland, USA (Press release, Grey Wolf Therapeutics, OCT 31, 2019, View Source [SID1234552970]). The company’s Head of Biology, Lesley Young, will be presenting a poster on Grey Wolf’s lead programme targeting ERAP1, showing that optimised ERAP1 inhibitors modify the immunopeptidome and generate novel, immunogenic neoantigens.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Poster number: P817

Presentation date and time: Friday 8th November from 7am-8pm.